“celgene” Archives

in
Entry Author Date Location
GV Taps Ex-Agios CEO Schenkein to Lead Life Science Investments 02/11/19 San Francisco
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
NYCEDC Finally Puts Its NY Bio Fund to Work With $60M For HiberCell 02/07/19 New York
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
With SEC Reopened, Gossamer Bio Turns Back from Alternative IPO Path 01/31/19 San Diego
Despite Buyout, Celgene Dealmaking Rolls On With Kyn, Obsidian Tie-Ups 01/18/19 Boston
Merck And The Future of Immuno-Oncology: A Chat With Roger Perlmutter 01/16/19 National
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More 01/11/19 National
Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More 01/07/19 National
Eli Lilly Makes an $8B Cancer Genetics Bet with Loxo Acquisition 01/07/19 Indiana
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More 01/04/19 National
Ribon Raises $65M to Pursue PARP-Blocking Pills for Cancer 01/04/19 Boston
In a Huge Biopharma Shakeup, Bristol-Myers to Buy Celgene For $74B 01/03/19 National
Gossamer Bio Files for IPO at End of Year in Which It Raised $330M 12/24/18 San Diego
15 for ’19: Key Clinical Data to Watch for Next Year (Part 1) 12/17/18 National
Bio Roundup: Eli Lilly Tries Tau, Generic Insulin, NASH Cash & More 12/14/18 National
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever 12/06/18 Boston
BCMA Day: At ASH ‘18, Cell Therapies For Myeloma Take Center Stage 12/04/18 National
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More 11/26/18 National
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More 11/16/18 National
Celgene Doubles Down on Dragonfly, Pays $50M to Expand Cancer Pact 11/14/18 Boston
Eyeing $500M, Moderna Outlines Plans for Biotech’s Biggest IPO Ever 11/09/18 Boston
Bashing Rival’s Pharma Record, Troubled Menendez Keeps NJ Senate Seat 11/07/18 New York
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front 10/23/18 National
Adynxx Agrees to Merger with Alliqua to Gain Public Stock Listing 10/12/18 San Francisco
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More 09/28/18 National
Six Life Science Firms Close Q3 with an IPO, More Are on the Way 09/28/18 Boston
Bio Roundup: Little Rhody, More for Migraine, Opioid Bills & More 09/21/18 National
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
Page 3 of 19 « previous page · next page »